Prospective multicenter evaluation of moving cell metallic stents in endoscopic multiple stent deployment for hepatic hilar obstruction

2021 ◽  
Author(s):  
Junichi Kawai ◽  
Takeshi Ogura ◽  
Mamoru Takenaka ◽  
Hideyuki Shiomi ◽  
Kazuya Ueshima ◽  
...  
Keyword(s):  
Metallic Stents ◽  
Stent Deployment

scholarly journals Multiple stenting in a patient with a high-grade malignant hilar biliary stricture: endoscopic four-branched partial stent-in-stent deployment of metallic stents

Endoscopy ◽  
2007 ◽  
Vol 39 (S 1) ◽  
pp. E167-E168 ◽  
Author(s):  
H. Kawamoto ◽  
K. Tsutsumi ◽  
M. Fujii ◽  
R. Harada ◽  
H. Kato ◽  
...  
Keyword(s):  
Biliary Stricture ◽  
Metallic Stents ◽  
High Grade ◽  
Stent Deployment ◽  
Hilar Biliary Stricture

Endoscopic 3-branched partial stent-in-stent deployment of metallic stents in high-grade malignant hilar biliary stricture (with videos)

2007 ◽  
Vol 66 (5) ◽  
pp. 1030-1037 ◽  
Author(s):  
Hirofumi Kawamoto ◽  
Koichiro Tsutsumi ◽  
Masakuni Fujii ◽  
Ryo Harada ◽  
Hironari Kato ◽  
...  
Keyword(s):  
Biliary Stricture ◽  
Metallic Stents ◽  
High Grade ◽  
Stent Deployment ◽  
Hilar Biliary Stricture

1481: Percutaneous Placement of Permanent Metallic Stents for Treatment of Ureteroenteric Anastomotic Strictures

2004 ◽  
Vol 171 (4S) ◽  
pp. 390-390
Author(s):  
David E. Rapp ◽  
Brett A. Laven ◽  
Gary D. Steinberg ◽  
Glenn S. Gerber
Keyword(s):  
Metallic Stents ◽  
Anastomotic Strictures

Treatment of Tracheobronchial Stenosis with a Self-Expandable Metallic Stents

1994 ◽  
Vol 31 (1) ◽  
pp. 35 ◽  
Author(s):  
Yo Won Choi ◽  
Yong Soo Kim ◽  
Seok Chol Jeon ◽  
Chang Kok Hahm ◽  
Chul Seung Choi
Keyword(s):  
Metallic Stents ◽  
Tracheobronchial Stenosis ◽  
Expandable Metallic Stents

Treatment of Malignant Esophageal Fistulas: Fluoroscopic Placement of Esophageal SEMS, Endoscopically-assisted through Surgical Gastrostomy. A Case Report

2016 ◽  
Vol 25 (2) ◽  
pp. 249-252 ◽  
Author(s):  
Gabriel Constantinescu ◽  
Vasile Şandru ◽  
Mădălina Ilie ◽  
Cristian Nedelcu ◽  
Radu Tincu ◽  
...  
Keyword(s):  
Esophageal Carcinoma ◽  
Guide Wire ◽  
Subsequent Development ◽  
Covered Stent ◽  
Metallic Stents ◽  
Fistula Formation ◽  
Life Threatening ◽  
Endoscopic Placement ◽  
Surgical Gastrostomy ◽  
Methods Of Treatment

Progressive esophageal carcinoma can infiltrate the surrounding tissues with subsequent development of a fistula, most commonly between the esophagus and the respiratory tract. The endoscopic placement of covered self-expanding metallic stents (SEMS) is the treatment of choice for malignant esophageal fistulas and should be performed immediately, as a fistula formation represents a potential life-threatening complication. We report the case of a 64-year-old male diagnosed with esophageal carcinoma, who had a 20Fr surgical gastrostomy tube inserted before chemo- and radiotherapy and was referred to our department for complete dysphagia, cough after swallowing and fever. The attempt to insert a SEMS using the classic endoscopic procedure failed. Then, a fully covered stent was inserted, as the 0.035” guide wire was passed through stenosis retrogradely by using an Olympus Exera II GIF-N180 (4.9 mm in diameter endoscope) via surgical gastrostomy, with a good outcome for the patient. The retrograde approach via gastrostomy under endoscopic/fluoroscopic guidance with the placement of a fully covered SEMS proved to be the technique of choice, in a patient with malignant esophageal fistula in whom other methods of treatment were not feasible. Abbreviations: ERCP: endoscopic retrograde cholangio-pancreatography; GI: gastrointestinal; SEMS: self-expandable metallic stents.

Optimum Therapies for ST-Elevation Myocardial Infarction Managed with Primary Percutaneous Coronary Intervention

2012 ◽  
Vol 7 (2) ◽  
pp. 81
Author(s):  
Bruce R Brodie ◽  
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Primary Percutaneous Coronary Intervention ◽  
Great Majority ◽  
Coronary Intervention ◽  
St Elevation Myocardial Infarction ◽  
Stent Deployment ◽  
Aspiration Thrombectomy ◽  
Percutaneous Coronary ◽  
St Elevation

This article reviews optimum therapies for the management of ST-elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PCI). Optimum anti-thrombotic therapy includes aspirin, bivalirudin and the new anti-platelet agents prasugrel or ticagrelor. Stent thrombosis (ST) has been a major concern but can be reduced by achieving optimal stent deployment, use of prasugrel or ticagrelor, selective use of drug-eluting stents (DES) and use of new generation DES. Large thrombus burden is often associated poor outcomes. Patients with moderate to large thrombus should be managed with aspiration thrombectomy and patients with giant thrombus should be treated with glycoprotein IIb/IIIa inhibitors and may require rheolytic thrombectomy. The great majority of STEMI patients presenting at non-PCI hospitals can best be managed with transfer for primary PCI even with substantial delays. A small group of patients who present very early, who are at high clinical risk and have long delays to PCI, may best be treated with a pharmaco-invasive strategy.

Sign in / Sign up

Export Citation Format

Share Document